IP Library Granted Patent US 10,052,319
Granted Patent B2
US 10,052,319 · App. 13/827,655 · Granted Aug 21, 2018

Medicament for treating mental and behavioural disorders

Inventor: Tsuyoshi Tsujimura (Osaka, JP)
Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
A61K31/496
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,319
App. No.
13/827,655
Granted
Aug 21, 2018
Kind
B2
Abstract

The present invention relates to a medicament comprising lurasidone or a pharmaceutically acceptable acid addition salt thereof for treating pervasive developmental disorders and a method of the treatment thereof.

Claims (5)

1. A method for treating at least one core symptom in autism, comprising:

administering a therapeutically effective amount of lurasidone or a pharmaceutically acceptable acid addition salt thereof as a sole active ingredient to a mammal in need thereof,

wherein the at least one core symptom is at least one of impairment in social adaptive function and impairment in communication.

2. The method of claim 1 , wherein the at least one core symptom is impairment in social adaptive function.

3. The method of claim 1 , wherein the at least one core symptom is impairment in communication.

Assignments (3)
CHANGE OF NAME Recorded Nov 21, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 061972/0730 →
CHANGE OF NAME Recorded Oct 7, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033905/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2013
From: TSUJIMURA, TSUYOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 030114/0281 →
Priority Claims (1)
JP 2012-100816 · Apr 26, 2012 · national
Continuity (2)
Provisional Application 61638725 · Apr 26, 2012
Related Publication 20130289277A1 · Oct 31, 2013